GLOBUS MEDICAL INC (GMED) earnings date, results and what the price requires
NYSE · SEC CIK 0001237831 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $789.6M | $151.6M | $1.10 | Filing |
| Mar 31, 2026 | May 7, 2026 | $759.9M | $124.3M | $0.90 | Filing |
| Dec 31, 2025 | Feb 24, 2026 | $826.4M | $140.6M | $1.01 | Filing |
| Sep 30, 2025 | Nov 6, 2025 | $769.0M | $119.0M | $0.88 | Filing |
| Jun 30, 2025 | Jul 21, 2025 | $745.3M | $202.8M | $1.49 | Filing |
| Mar 31, 2025 | May 8, 2025 | $598.1M | $75.5M | $0.54 | Filing |
| Dec 31, 2024 | Feb 20, 2025 | $657.3M | $26.5M | $0.19 | Filing |
| Sep 30, 2024 | Nov 5, 2024 | $625.7M | $51.8M | $0.38 | Filing |
What would GLOBUS MEDICAL INC have to report for its valuation to change?
At $76.71, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 11.0% a year, to $6.56. On that path the next quarter needs diluted EPS near $0.98, against $0.88 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 11.0% | 11.0% |
| EPS needed in final year | $6.56 | $6.56 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. GMED goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.